Study for people transitioning gender-affirming care

This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.

This trial is designed to improve how healthcare is provided to young people who are exploring their gender identity. If you have already been accepted into a gender identity service, you may be able to join and help shape better care for others.

This study looks at how gender-affirming hormone therapy affects the heart and blood vessels in transgender people. If you've been on hormones for at least a year, researchers want to check your cardiovascular health to better understand long-term risks and benefits.

This study follows transgender and gender diverse people of all ages 16 and older to learn more about their health and well-being over time. It is for those who have a diagnosis of gender incongruence and are either starting, continuing, or have stopped gender affirming therapy.

This study looks back at the medical records of transgender young people who began gender-affirming care at Strasbourg University Hospital before age 18. It helps doctors understand their experiences and improve future care.

This study focuses on adults (18+) who are transgender and have not started hormone treatment yet. It aims to better understand gender incongruence and support care planning.